Breath profiles of children on ketogenic therapy

Journal of Breath Research
V RuzsanyiMatthias Baumann

Abstract

Ketogenic diets (KDs) were initially introduced to clinical practices as alimentary approaches with the aim to control drug-resistant epilepsies. Over the decades, a large and growing body of research has addressed the antiseizure effect of various KDs, and worked out KD-based dietary regimens, including their acting factors and modes of action. KDs have also appeared in weight loss therapies. Therapy control, particularly at initiation, happens through regular blood analysis and control of urine ketone levels. However, there is a lack of fast, reliable, and preferably non-invasive methods to accomplish this. The detection of exhaled breath constituents may offer a solution. The exhaled breath contains hundreds of volatile organic compounds (VOCs), which can be modified by diet. VOC detection technology has resulted in low-cost sensors that can facilitate the self-monitoring of patients in the future if reliable breath markers are available. Therefore, it is of interest to investigate the composition of exhaled breath in children on KDs. Twenty-two pediatric patients between 4 and 18 years of age were recruited in this study. Eleven of them received a KD and suffered from epilepsy, with the exception of one child, who was admit...Continue Reading

References

Apr 1, 1979·The Journal of Clinical Investigation·G A ReichardO E Owen
Oct 1, 1976·Archives of Biochemistry and Biophysics·K TakayamaG Cilento
Oct 15, 1989·The Biochemical Journal·M C SugdenT N Palmer
Oct 1, 1987·Biochemical Society Transactions·P JonesD R Critchley
Mar 19, 1970·The New England Journal of Medicine·G F Cahill
Nov 3, 1998·Archives of Disease in Childhood. Fetal and Neonatal Edition·J A NycykR W Cooke
Sep 8, 2000·Medicine, Science, and the Law·B K Logan, A W Jones
Jun 26, 2002·The American Journal of Clinical Nutrition·Kathy Musa-VelosoStephen C Cunnane
Aug 24, 2002·Pediatric Research·Kathy Musa-VelosoStephen Cunnane
Feb 11, 2004·Prostaglandins, Leukotrienes, and Essential Fatty Acids·K Musa-Veloso
May 7, 2005·Journal of Inherited Metabolic Disease·A A M Morris
May 19, 2007·Pediatric Neurology·Adam L HartmanMichael A Rogawski
Aug 1, 2007·Rejuvenation Research·Rafal R NazarewiczPedram Ghafourifar
Oct 10, 2007·Epilepsia·Miklós Péter Kalapos
Jun 19, 2009·Journal of Child Neurology·Eric H KossoffJong M Rho
Jan 12, 2010·Comparative Biochemistry and Physiology. Part A, Molecular & Integrative Physiology·Marshall D McCue
Feb 1, 1947·Proceedings of the Society for Experimental Biology and Medicine·R L DRIVER
Mar 1, 2009·Journal of Breath Research·S ErhartS Scholl-Bürgi
Aug 23, 2011·Epilepsy Research·A G Christina Bergqvist
Mar 1, 2012·Physiological Measurement·Julian KingBirgit Högl
Oct 18, 2012·American Journal of Physiology. Endocrinology and Metabolism·Maarten R SoetersJohannes A Romijn
Jan 2, 2014·Seizure : the Journal of the British Epilepsy Association·Giangennaro CoppolaAlberto Verrotti
Mar 15, 2014·Epilepsy Research and Treatment·Suvasini Sharma, Puneet Jain
Jan 23, 2015·Journal of Exercise Rehabilitation·Hyun-Seung RhyuHee-Tae Roh
Jun 20, 2015·Cellular and Molecular Gastroenterology and Hepatology·Cristina Llorente, Bernd Schnabl
Nov 18, 2015·Clinical Liver Disease·Irina A KirpichCraig J McClain
Jan 23, 2016·Acta neurologica Belgica·Gholam Reza ZamaniReza Azizi Malamiri
Sep 7, 2016·Molecular Autism·Christopher NewellJane Shearer
Jun 6, 2017·Neurochemistry International·Scott J Koppel, Russell H Swerdlow

❮ Previous
Next ❯

Related Concepts

Related Feeds

ApoE, Lipids & Cholesterol

Serum cholesterol, triglycerides, apolipoprotein B (APOB)-containing lipoproteins (very low-density lipoprotein (VLDL), immediate-density lipoprotein (IDL), and low-density lipoprotein (LDL), lipoprotein A (LPA)) and the total cholesterol/high-density lipoprotein (HDL) cholesterol ratio are all connected in diseases. Here is the latest research.